Northrop Grumman (NYSE: NOC) exec sells shares and sees stock awards vest
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Northrop Grumman executive Benjamin R. Davies, Corporate Vice President and President of Defense Systems, reported several stock transactions. He sold 2,189.04 shares of common stock in an open‑market sale at a weighted average price of $719.61 per share, leaving 151 shares held directly.
On the prior day, 274 restricted stock rights were exercised into the same number of common shares, and 123 shares were withheld at $701.12 per share to cover tax obligations. Davies now holds 6,444 restricted stock rights that are scheduled to vest in stages between 2026 and 2029.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 2,189.04 shares ($1,575,255)
Net Sell
5 txns
Insider
Davies Benjamin R.
Role
CVP & Pres. Defense Systems
Sold
2,189.04 shs ($1.58M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,189.04 | $719.61 | $1.58M |
| Exercise | Restricted Stock Rights | 274 | $0.00 | -- |
| Exercise | Common Stock | 274 | $0.00 | -- |
| Tax Withholding | Common Stock | 123 | $701.12 | $86K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 151 shares (Direct);
Restricted Stock Rights — 6,444 shares (Direct);
Common Stock — 0.002 shares (Indirect, Held in Northrop Grumman Savings Plan)
Footnotes (1)
- Represents the weighted average sale price of $719.61 rounded to the nearest hundredth. The highest price at which the shares were sold was $719.935 and the lowest price at which the shares were sold was $719.55. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Held in the Northrop Grumman Savings Plan (the "Plan"), a qualified defined contribution plan, as of February 17, 2026. Share totals with respect to the Plan are based upon unit accounting and therefore may reflect a change in units attributable to an individual though no acquisition or disposition occurred. Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. Shares issued upon vesting of RSRs granted under the 2011 Long-Term Incentive Stock Plan ("2011 LTISP") on 2/16/23 that vested on 2/17/26. Total amount includes (i) 641 RSRs granted under the 2011 LTISP on 11/1/23 that will vest on 11/2/26; (ii) 1,008 RSRs granted under the 2011 LTISP on 2/14/24 that will vest on 2/16/27; (iii) 638 RSRs granted under the 2011 LTISP on 7/31/24 that will vest on 8/2/27; (iv) 2,456 RSRs granted under the 2024 LTISP on 2/18/25 that will vest on 2/18/28; and (v) 1,701 RSRs granted under 2024 LTISP on 2/11/26 that will vest on 2/12/29.
FAQ
What insider transactions did Northrop Grumman (NOC) report for Benjamin R. Davies?
Benjamin R. Davies reported an open-market sale of 2,189.04 Northrop Grumman common shares and multiple related equity award transactions, including the vesting and exercise of 274 restricted stock rights and a tax-withholding disposition of 123 shares tied to those awards.
What equity awards vested for Benjamin R. Davies in the latest Northrop Grumman (NOC) Form 4?
274 restricted stock rights vested and were converted into 274 common shares. These awards were originally granted under Northrop Grumman’s long-term incentive stock plan and became deliverable on February 17, 2026, creating the corresponding acquisition of common stock reported in the filing.
What restricted stock rights does Benjamin R. Davies still hold in Northrop Grumman (NOC)?
He holds 6,444 restricted stock rights, each representing a contingent claim on one share or cash equivalent. These rights come from multiple grants under long-term incentive plans and are scheduled to vest in separate tranches between 2026 and 2029.